Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples